Efficacy and Safety of the Anti-PD-L1 mAb Socazolimab for Recurrent or Metastatic Cervical Cancer: a Phase I Dose-Escalation and Expansion Study.

Jusheng An,Jie Tang,Benjamin X Li, Huihua Xiong,Hui Qiu,Lin Luo,Li Wang,Danbo Wang,Qi Zhou,Qin Xu,Honglin Song,Yunyan Zhang,Hongping Zhang, Yujie Li, Xiaohui Yu,Jing Zhang,Rachel Ng, Wayne Zhao,Michael Wong,Xiangrong Dai,Guiling Li,Lingying Wu

Clinical cancer research : an official journal of the American Association for Cancer Research（2022）

引用 6|浏览20

暂无评分

摘要

Our study demonstrates that socazolimab has durable safety and efficacy for the treatment of recurrent or metastatic cervical cancer and exhibits a safety profile similar to other anti-PD-1/PD-L1 mAbs.

查看译文

关键词

metastatic cervical cancer,cervical cancer,dose-escalation

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要